![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.54% | 1.65 | 1.60 | 1.70 | 1.70 | 1.625 | 1.63 | 27,752,936 | 15:13:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.74 | 8.96M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/1/2021 13:27 | BUYERS PUSHING share price back up more already not even 2pm yet ,how strong an afternoon looks to be ahead with this buying already will 90 p be passed or a £1 be passed this afternoon | ![]() bunz3 | |
28/1/2021 13:13 | SOME Chunky buys | ![]() bunz3 | |
28/1/2021 13:00 | Well, we already have lift off!🔥㉀ To the moon it is then!!!!!📈 | uk2day | |
28/1/2021 12:55 | Can you imagine if they reveal contract revenue on the scale of NCYT for the next 6 months......with the number of shares in circulation and market cap, the price will be more than moonshot....another bloody galaxy!!! | ![]() k1ngkonggb | |
28/1/2021 12:51 | How many shorters were toast after todays RNS?😂㈳ | uk2day | |
28/1/2021 12:48 | how many building up holdings for February after Todays rns | ![]() bunz3 | |
28/1/2021 12:41 | BC to release statement at 1:30 GMT | hooded claw | |
28/1/2021 12:38 | Good luck to you guysIve taken my 22k profit after a long wait... and it was a long wait | phurley | |
28/1/2021 12:36 | was some one silly enough to short a share like gdr with so much good news due , as has been Today again Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing | ![]() bunz3 | |
28/1/2021 12:34 | When USA awakens rthen be interesting to see how this moves with Todays rns and Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing | ![]() bunz3 | |
28/1/2021 12:33 | justtrying1 - 28 Jan 2021 - 11:10:25 - 3396 of 3419 Price dropping now Lol you posted this at 73p!😂㈳ Fool!!!! | uk2day | |
28/1/2021 12:30 | so strong of buying when USA Markets poen how interesting might be to watch then | ![]() bunz3 | |
28/1/2021 12:25 | 25 ,000 share buy | ![]() bunz3 | |
28/1/2021 12:24 | When USA awakens rthen be interesting to see how this moves with Todays rns and Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing | ![]() bunz3 | |
28/1/2021 12:18 | The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. | ![]() bunz3 | |
28/1/2021 12:17 | David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously. "We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products." The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. | ![]() bunz3 | |
28/1/2021 12:15 | when USA market opens ,Will interest be seen from USA around 2pm 0r 3pm | ![]() bunz3 | |
28/1/2021 12:13 | The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. | ![]() bunz3 | |
28/1/2021 12:12 | David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously. "We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products." The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations. | ![]() bunz3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions